Paragon 28, Inc. (FNA)

USD 12.99

(0.04%)

Total Liabilities Summary of Paragon 28, Inc.

  • Paragon 28, Inc.'s latest annual total liabilities in 2023 was 162.95 Million USD , up 43.98% from previous year.
  • Paragon 28, Inc.'s latest quarterly total liabilities in 2024 Q1 was 170.11 Million USD , up 4.39% from previous quarter.
  • Paragon 28, Inc. reported annual total liabilities of 113.18 Million USD in 2022, up 167.25% from previous year.
  • Paragon 28, Inc. reported annual total liabilities of 42.35 Million USD in 2021, up 62.28% from previous year.
  • Paragon 28, Inc. reported quarterly total liabilities of 170.11 Million USD for 2024 Q1, up 4.39% from previous quarter.
  • Paragon 28, Inc. reported quarterly total liabilities of 108.39 Million USD for 2023 Q1, down -4.23% from previous quarter.

Annual Total Liabilities Chart of Paragon 28, Inc. (2023 - 2019)

Historical Annual Total Liabilities of Paragon 28, Inc. (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 162.95 Million USD 43.98%
2022 113.18 Million USD 167.25%
2021 42.35 Million USD 62.28%
2020 26.09 Million USD -44.83%
2019 47.3 Million USD 0.0%

Peer Total Liabilities Comparison of Paragon 28, Inc.

Name Total Liabilities Total Liabilities Difference
Abbott Laboratories 34.38 Billion USD 99.526%
Allurion Technologies Inc. 142.19 Million USD -14.599%
Artivion, Inc. 510.61 Million USD 68.086%
Avanos Medical, Inc. 456.1 Million USD 64.271%
Butterfly Network, Inc. 84.22 Million USD -93.489%
Butterfly Network, Inc. 84.22 Million USD -93.489%
Bio-Rad Laboratories, Inc. 3.55 Billion USD 95.42%
Boston Scientific Corporation 15.6 Billion USD 98.956%
CONMED Corporation 1.46 Billion USD 88.883%
Edwards Lifesciences Corporation 2.64 Billion USD 93.836%
Glaukos Corporation 478.64 Million USD 65.955%
Globus Medical, Inc. 1.08 Billion USD 85.024%
Inspire Medical Systems, Inc. 104.29 Million USD -56.244%
Integer Holdings Corporation 1.41 Billion USD 88.469%
Medtronic plc 39.56 Billion USD 99.588%
Myomo, Inc. 5.59 Million USD -2814.014%
Nevro Corp. 330.31 Million USD 50.665%
Owlet, Inc. 73.79 Million USD -120.813%
Penumbra, Inc. 377.36 Million USD 56.816%
Vicarious Surgical Inc. 21.89 Million USD -644.27%
Smith & Nephew plc 4.77 Billion USD 96.584%
Sonendo, Inc. 49.74 Million USD -227.613%
STERIS plc 4.74 Billion USD 96.568%
Stryker Corporation 21.31 Billion USD 99.236%
Vapotherm, Inc. 132.95 Million USD -22.57%
Zimmer Biomet Holdings, Inc. 9 Billion USD 98.191%